Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 1
1968 1
1972 1
1973 8
1974 4
1975 2
1976 2
1977 4
1978 3
1979 1
1980 7
1981 8
1982 13
1983 13
1984 11
1985 18
1986 16
1987 17
1988 7
1989 24
1990 33
1991 24
1992 25
1993 24
1994 19
1995 16
1996 17
1997 23
1998 19
1999 17
2000 16
2001 15
2002 12
2003 19
2004 6
2005 5
2006 10
2007 9
2008 6
2009 8
2010 5
2011 11
2012 10
2013 9
2014 8
2015 15
2016 11
2017 11
2018 7
2019 15
2020 10
2021 19
2022 15
2023 14
2024 11
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

627 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.
Tykodi SS, Gordan LN, Alter RS, Arrowsmith E, Harrison MR, Percent I, Singal R, Van Veldhuizen P, George DJ, Hutson T, Zhang J, Zoco J, Johansen JL, Rezazadeh Kalebasty A. Tykodi SS, et al. Among authors: harrison mr. J Immunother Cancer. 2022 Feb;10(2):e003844. doi: 10.1136/jitc-2021-003844. J Immunother Cancer. 2022. PMID: 35210307 Free PMC article. Clinical Trial.
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial.
Yu EY, Petrylak DP, O'Donnell PH, Lee JL, van der Heijden MS, Loriot Y, Stein MN, Necchi A, Kojima T, Harrison MR, Hoon Park S, Quinn DI, Heath EI, Rosenberg JE, Steinberg J, Liang SY, Trowbridge J, Campbell M, McGregor B, Balar AV. Yu EY, et al. Among authors: harrison mr. Lancet Oncol. 2021 Jun;22(6):872-882. doi: 10.1016/S1470-2045(21)00094-2. Epub 2021 May 12. Lancet Oncol. 2021. PMID: 33991512 Clinical Trial.
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.
Tannir NM, Signoretti S, Choueiri TK, McDermott DF, Motzer RJ, Flaifel A, Pignon JC, Ficial M, Frontera OA, George S, Powles T, Donskov F, Harrison MR, Barthélémy P, Tykodi SS, Kocsis J, Ravaud A, Rodriguez-Cid JR, Pal SK, Murad AM, Ishii Y, Saggi SS, McHenry MB, Rini BI. Tannir NM, et al. Among authors: harrison mr. Clin Cancer Res. 2021 Jan 1;27(1):78-86. doi: 10.1158/1078-0432.CCR-20-2063. Epub 2020 Sep 1. Clin Cancer Res. 2021. PMID: 32873572 Free PMC article.
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
Motzer RJ, Rini BI, McDermott DF, Arén Frontera O, Hammers HJ, Carducci MA, Salman P, Escudier B, Beuselinck B, Amin A, Porta C, George S, Neiman V, Bracarda S, Tykodi SS, Barthélémy P, Leibowitz-Amit R, Plimack ER, Oosting SF, Redman B, Melichar B, Powles T, Nathan P, Oudard S, Pook D, Choueiri TK, Donskov F, Grimm MO, Gurney H, Heng DYC, Kollmannsberger CK, Harrison MR, Tomita Y, Duran I, Grünwald V, McHenry MB, Mekan S, Tannir NM; CheckMate 214 investigators. Motzer RJ, et al. Among authors: harrison mr. Lancet Oncol. 2019 Oct;20(10):1370-1385. doi: 10.1016/S1470-2045(19)30413-9. Epub 2019 Aug 16. Lancet Oncol. 2019. PMID: 31427204 Free PMC article. Clinical Trial.
Fetal therapy.
Evans MI, Harrison MR, Flake AW, Johnson MP. Evans MI, et al. Among authors: harrison mr. Best Pract Res Clin Obstet Gynaecol. 2002 Oct;16(5):671-83. doi: 10.1053/beog.2002.0331. Best Pract Res Clin Obstet Gynaecol. 2002. PMID: 12475547 Review.
Fetal surgery.
Harrison MR. Harrison MR. West J Med. 1990 Dec;153(6):648. West J Med. 1990. PMID: 2293474 Free PMC article. No abstract available.
Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer.
Beckabir W, Wobker SE, Damrauer JS, Midkiff B, De la Cruz G, Makarov V, Flick L, Woodcock MG, Grivas P, Bjurlin MA, Harrison MR, Vincent BG, Rose TL, Gupta S, Kim WY, Milowsky MI. Beckabir W, et al. Among authors: harrison mr. Eur Urol. 2024 Mar;85(3):242-253. doi: 10.1016/j.eururo.2023.11.008. Epub 2023 Dec 12. Eur Urol. 2024. PMID: 38092611 Free PMC article.
Presidential Forum.
Ellison EC, Ponsky JL, Harrison MR, McGrath MH, Angelos P, Krummel TM. Ellison EC, et al. Among authors: harrison mr. Ann Surg. 2019 Oct;270(4):573-584. doi: 10.1097/SLA.0000000000003421. Ann Surg. 2019. PMID: 31274654 No abstract available.
Biomaterials in fetal surgery.
Winkler SM, Harrison MR, Messersmith PB. Winkler SM, et al. Among authors: harrison mr. Biomater Sci. 2019 Aug 1;7(8):3092-3109. doi: 10.1039/c9bm00177h. Epub 2019 May 17. Biomater Sci. 2019. PMID: 31099350 Free PMC article. Review.
Congenital diaphragmatic hernia.
Harrison MR, de Lorimier AA. Harrison MR, et al. Surg Clin North Am. 1981 Oct;61(5):1023-35. doi: 10.1016/s0039-6109(16)42528-4. Surg Clin North Am. 1981. PMID: 7031926 Review.
627 results